Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology

Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology

Item
http://www.wikidata.org/entity/Q33501446
Phase II trial of oral aminopterin for adults and children with refractory acute leukemiaOptimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology groupRisk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic lContribution of tumoral and host solute carriers to clinical drug response.Neurocognitive function after radiotherapy for paediatric brain tumours.Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate.
P2860

Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology

Item
http://www.wikidata.org/entity/Q33501446
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Intermediate-dose intravenous ...... leukemia: a Pediatric Oncology
@ast
Intermediate-dose intravenous ...... leukemia: a Pediatric Oncology
@en
type
label
Intermediate-dose intravenous ...... leukemia: a Pediatric Oncology
@ast
Intermediate-dose intravenous ...... leukemia: a Pediatric Oncology
@en
prefLabel
Intermediate-dose intravenous ...... leukemia: a Pediatric Oncology
@ast
Intermediate-dose intravenous ...... leukemia: a Pediatric Oncology
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Intermediate-dose intravenous ...... leukemia: a Pediatric Oncology
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921